Charles York
Director of Finance/CFO presso DAY ONE BIOPHARMACEUTICALS, INC.
Patrimonio netto: 4 M $ in data 31/03/2024
Profilo
Charles N.
York is currently the Chief Operating & Financial Officer at DOT Therapeutics-2, Inc. and the Chief Operating & Financial Officer, Secretary at Day One Biopharmaceuticals, Inc. Previously, he worked as the Controller at Astrotech Corp.
from 2009 to 2012 and as the Chief Financial Officer, Secretary & VP at Spyre Therapeutics, Inc. from 2014 to 2021.
Mr. York obtained his undergraduate degree from the University of Connecticut in 1999 and his MBA from the McCombs School of Business in 2006.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 03/05/2024 | 217 293 ( 0.25% ) | 4 M $ | 31/03/2024 |
Posizioni attive di Charles York
| Società | Posizione | Inizio |
|---|---|---|
| DAY ONE BIOPHARMACEUTICALS, INC. | Director of Finance/CFO | 01/02/2021 |
DOT Therapeutics-2, Inc.
 DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA. | Director of Finance/CFO | 17/02/2021 |
Precedenti posizioni note di Charles York
| Società | Posizione | Fine |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Director of Finance/CFO | 12/02/2021 |
| ASTROTECH CO. | Comptroller/Controller/Auditor | 01/08/2012 |
Formazione di Charles York
| University of Connecticut | Undergraduate Degree |
| McCombs School of Business | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| ASTROTECH CO. | Electronic Technology |
| SPYRE THERAPEUTICS, INC. | Health Technology |
| DAY ONE BIOPHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
DOT Therapeutics-2, Inc.
DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Charles York
